Site-Specific N-Glycoproteomic Analysis Reveals Upregulated Sialylation and Core Fucosylation during Transient Regeneration Loss in Neonatal Mouse Hearts.
Jun LiLi JiaZhifang HaoYintai XuJiechen ShenChen MaJingyu WuTing ZhaoYuan ZhiPengfei LiJing LiBojing ZhuShisheng SunPublished in: Journal of proteome research (2020)
Myocardial infarction (MI) is one of the leading causes of deaths worldwide. Because of the incapability of regeneration, the cardiomyocyte loss with MI is replaced by fibrotic scar tissue, which eventually leads to heart failure. Reconstructing regeneration of an adult human heart has been recognized as a promising strategy for cardiac therapeutics. A neonatal mouse heart, which possesses transient regenerative capacity at the first week after birth, represents an ideal model to investigate processes associated with cardiac regeneration. In this work, an integrated glycoproteomic and proteomic analysis was performed to investigate the differences in glycoprotein abundances and site-specific glycosylation between postneonatal day 1 (P1) and day 7 (P7) of mouse hearts. By large-scale profiling and quantifying more than 2900 intact N-glycopeptides in neonatal mouse hearts, we identified 227 altered N-glycopeptides between P1 and P7 hearts. By extracting protein changes from the global proteome data, the normalized glycosylation changes for site-specific glycans were obtained, which showed heterogeneity on glycosites and glycoproteins. Systematic analysis of the glycosylation changes demonstrated an overall upregulation of sialylation and core fucosylation in P7 mice. Notably, the upregulated sialylation was a comprehensive result of increased sialylated glycans with Neu5Gc, with both Neu5Gc and core fucose, and decreased sialylated glycans with Neu5Ac. The upregulated core fucosylation resulted from the increase of glycans containing both core fucose and Neu5Gc but not glycans containing sole core fucose. These data provide a valuable resource for future functional and mechanism studies on heart regeneration and discovery of novel therapeutic targets. All mass spectrometry proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the data set identifier PXD017139.
Keyphrases
- stem cells
- heart failure
- electronic health record
- left ventricular
- mass spectrometry
- big data
- cell surface
- wound healing
- atrial fibrillation
- small molecule
- single cell
- endothelial cells
- gas chromatography
- mesenchymal stem cells
- systemic sclerosis
- idiopathic pulmonary fibrosis
- machine learning
- metabolic syndrome
- cell therapy
- cell proliferation
- pregnant women
- bone marrow
- cerebral ischemia
- hepatitis c virus
- blood brain barrier
- data analysis
- poor prognosis
- adipose tissue
- angiotensin ii
- high resolution
- tandem mass spectrometry
- tissue engineering